Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211

NEXT STORY
Cytokinetics Announces New Results Presented at the International Symposium on ALS/MND
PREV STORY
Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

American Gene Technologies to Present at 2020 Virtual Cell & Gene Meeting on the Mesa

author_avatar
NASDAQ Market News

Summary of Recent Published Research on Delcath’s PHP Therapy Presented at Society of Surgical Oncology Annual Symposia

NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...

author_avatar
NASDAQ Market News

MediciNova Announces Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model to be Presented at The Liver Meeting Digital Experience™ 2020

author_avatar
NASDAQ Market News